Skip to content

Glucose Frequent of A1GDM in Labor

Glucose Monitoring for A1GDM

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06744621
Enrollment
100
Registered
2024-12-20
Start date
2024-12-05
Completion date
2025-05-30
Last updated
2025-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes, Controlled by Diet

Brief summary

This is a prospective double arm study in patients with Gestational Diabetes Mellitus (GDM) utilizing frequent (single fingerstick on admission) vs infrequent glucose monitoring in labor (q 4 hours in latent labor and every 2 hours in active labor). Primary Objective: The primary outcome is glucose value of the neonate at birth. Secondary Objectives: Determine rates of insulin requirements within different monitoring techniques. Determine if there is a difference in neonatal intensive care unit (NICU) admission within different monitoring techniques. Determine neonatal blood glucose concentrations at 24 hours of life, number of glucose treatments, and neonatal hyperbilirubinemia. Secondary characteristics to be viewed for each diagnosis; BMI, race, age, and parity.

Interventions

fingersticks during their labor process

Sponsors

Icahn School of Medicine at Mount Sinai
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 51 Years
Healthy volunteers
No

Inclusion criteria

* All female patients of reproductive age (menarche-menopause: 18-51 years) who have the diagnosis diet controlled GDM * Patient with singleton gestation presenting in labor or for induction * Patients who had good glucose control and were A1GDM. Good Control; * \- Patient with overall outpatient glucose average of less than 100 * \- No evidence of fetopathy, large for gestational age or polyhydramnios. * \- Hgb A1c \<5.7

Exclusion criteria

• If patient's admission accu check is \>120

Design outcomes

Primary

MeasureTime frame
Neonatal glucose levelat 24 hours

Secondary

MeasureTime frame
Number of neonates requiring insulinat 24 hours
Number of NICU admissionsat 24 hours
Number of glucose treatmentsat 24 hours
Number of neonatal with hyperbilirubinemiaat 24 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026